glp 1 mw GLP-1 Advanced Metabolic Extra Strength Glucagon-like peptide-1 - Wikipedia

10.1016/j.yexcr.2009.06.018 45 HorisawaK.UdonoM.UenoK.OhkawaY.NagasakiM.SekiyaS.et al (2020)

Choose Injectable Delivery When: Maximum bioavailability and systemic distribution are required Your peptide has a molecular weight exceeding 6,000 Da Precise dosing and reproducible pharmacokinetics are necessary Youre using peptides for bodybuilding or muscle growth The peptide lacks CNS targets Choose Nasal Delivery When: Direct CNS delivery and blood-brain barrier bypass are therapeutic objectives Your peptide is small (under 6,000 Da) and shows adequate nasal bioavailability Rapid onset of action (minutes) is clinically valuable Patient compliance and comfort are primary concerns Youre using neurological peptides like Semax or Selank The FDA has approved several intranasal peptide formulations, including ZAVZPRET for acute migraine treatment, validating this delivery route as pharmaceutically viable

Due to this mechanism of action, there is a slower release of Growth Hormone which makes it more natural

Consult your doctor before use in case of any medical condition, pregnancy, or medication